Raymond James Financial Inc Minerva Neurosciences, Inc. Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Minerva Neurosciences, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 25 shares of NERV stock, worth $44. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25Holding current value
$44% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NERV
# of Institutions
20Shares Held
1.94MCall Options Held
0Put Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA1.35MShares$2.38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA252KShares$443,6250.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny111KShares$195,3600.0% of portfolio
-
Geode Capital Management, LLC Boston, MA75.6KShares$133,1000.0% of portfolio
-
Black Rock Inc. New York, NY72.7KShares$127,8970.0% of portfolio
About Minerva Neurosciences, Inc.
- Ticker NERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,340,190
- Market Cap $9.4M
- Description
- Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein ...